Search Results
29 results found-
Water consumption (GL) consumption Water 25 The increase in waste is driven mainly 2 20 by an increase in production and the 200 2 intensity reductions is largely due to per US$ million revenue) (kilolitres 15 1 overall company performance (group per US$ million revenue) tonnes (metric 100 10 1 revenue).
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2020-full.pdf -
Biotech leader CSL has manufacturing centers, sales offices, and locations to serve patients and public health around the globe.
https://www.csl.com/we-are-csl/worldwide-locations -
8 CSL Limited Annual Report 2018 3.0 800 8000 1500 700 7000 2.5 1200 600 6000 2.0 5000 500 900 1.5 400 4000 300 3000 600 1.0 200 2000 300 0.5 100 1000 0.0 0 0 0
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2018-full.pdf -
LTI as a percentage of fixed remuneration LTI as a percentage of fixed remuneration LTI Performance Rights - Target 300 LTI Performance Rights - Target LTI Performance Rights - Maximum LTI Performance Rights - Maximum LTI Performance Options - Target 250 LTI Performance Options - Target 200 80% 80% 150 15% 15% 50% 50% % % 50% 50% % % 100 40% 45 45 40% 40% 45 45 40% 8% 8% 8% 8% 8% 8% 8% 8% 8% 8% 8% 8% 8% 8% 8% 8% 50 120% 65% 65% 65% 65% 65% 65% 65% 65% 120% 65% 65% 65% 65% 65% 65% 65% 65% 0 L Reed L Reed G Boss G Boss G Naylor G Naylor R Repella R Repella D Lamont D Lamont P Perreault P Perreault V Romberg V Romberg K Etchberger K Etchberger A Cuthbertson A Cuthbertson
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2017-full.pdf -
CSL's Speak Up hotline can be accessed by toll-free numbers or online and is promoted periodically through employee communications and trainings.
https://www.csl.com/-/media/csl/documents/csl-statement-on-modern-slavery-2023.pdf -
ST. GALLEN, SWITZERLAND, March 28, 2024 / PRNewswire / -- CSL Vifor is pleased that its partner Akebia Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least three months.
https://newsroom.csl.com/2024-03-28-Vafseo-R-approved-by-the-U-S-FDA-for-the-treatment-of-anemia-due-to-chronic-kidney-disease-in-dialysis-dependent-adult-patients -
link, to access the online Impact RAP Impact Measurement Questionnaire.
https://www.csl.com/-/media/shared/documents/reconciliation-action-plan/csl-reflect-reconciliation-action-plan-rap-2023.pdf -
1500 300 20% 1000 1000 200 15% 10% 500 500 100 5%
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2019-full.pdf -
If you have a rare or chronic condition, start with your doctor and patient advocacy organizations.
https://www.csl.com/we-are-csl/vita-original-stories/2024/looking-for-reliable-health-info